Results 261 to 270 of about 3,739,846 (342)

EUROHELICAN-The First Helicobacter Pylori Screen-and-Treat Population-Based Study in Young Adults in Europe. [PDF]

United European Gastroenterol J
Tepeš B, Bric TK, Završnik J, Oblak M, Kralj M, Polajžer A, Vošner HB, Lorber NM, Park JY, Matysiak-Budnik T.   +9 more
europepmc   +1 more source

The Economic Burden of Gastric Cancer: A Systematic Review

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Gastric cancer is the fifth most common cancer, as well as the fourth leading cause of cancer‐related mortality. It significantly burdens patients, families, and the healthcare system. Considering this large economic impact, this review study aims to evaluate the total economic burden of gastric cancer. Methods An extensive
Mohadeseh Ghanbari‐Jahromi, Najmeh Bordbar, Faride Sadat Jalali   +2 more
wiley   +1 more source

Autoimmune Gastritis Associated With a Gastric Hyperplastic Polyp: Two Case Reports and Review of its Neoplastic Potential. [PDF]

Korean J Helicobacter Up Gastrointest Res
Lee MH, Kim SE, Park MI, Jung K.
europepmc   +1 more source

Evaluating Lifestyle and Educational Factors Influencing Public Knowledge, Attitudes, and Practices Toward Helicobacter pylori‐Induced Gastric Ulcer: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Helicobacter pylori (H. pylori)‐induced gastric ulcer is a public health challenge in Pakistan. The current study examined the knowledge, attitudes, and practices regarding H. pylori‐induced gastric ulcers among the general Pakistani population.
Asma Ghulam Mustafa, Adeel Aslam, Muhammad Aamir, Shazia Jamshed, Sumera Saeed Akhtar   +4 more
wiley   +1 more source

Clinical management of gastric mucosa-associated lymphoid tissue lymphoma. [PDF]

Korean J Intern Med
Ahn JY.
europepmc   +1 more source

Establishment of Reference Interval for CA72‐4 in Healthy Adults in Shenzhen, China

Journal of Clinical Laboratory Analysis, Volume 40, Issue 7, April 2026.
We established a reference interval (RI) for serum CA72‐4 in healthy adults in Shenzhen, China, based on data from 2614 individuals. Using CLSI EP28‐A3c guidelines, we determined an upper reference limit of 8.5 U/mL, which significantly reduced false‐positive results compared to the manufacturer's cutoff.
Mengting An, Zhiling Xu, Yanan Zhang, Junjie Wan   +3 more
wiley   +1 more source

Efficacy and Safety of Minocycline-Containing Bismuth Quadruple Therapies Versus Standard First-Line Bismuth Quadruple Therapies for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis. [PDF]

Infect Dis Rep
Wazir HU, Khuram AM, Reza IMK, Ajmal H, Parveen H, Ahmed Z, Iftequar Y, Inam N, Sulaiman IM, Tummala N, Sajid HMM, Khan AZ, Shafaqat U.   +12 more
europepmc   +1 more source

An Engineered Nano‐Vesicle Adjuvant Platform (ENAP) for Cytokine Delivery Enables a Novel Antigen‐Coordinated Vaccine Against Helicobacter pylori

Journal of Extracellular Vesicles, Volume 15, Issue 4, April 2026.
ABSTRACT Despite the considerable potential of Helicobacter pylori (H. pylori) vaccines, their clinical efficacy has been hampered by inadequate mucosal immunity and suboptimal Th1/Th17 polarization. To address this, we engineered a novel nano‐adjuvant system using LPS‐modified recombinant outer membrane vesicles (rOMVs) derived from H.
Yinpan Shang, Xiran Zhang, Linwei Li, Xiaomin Yu, Lingbing Zeng, Yanli Cao, Ziwei Tao, Lu Shen, Shuaishuai Zhang, Chuangye Yang, Huizhen Tian, Ying Liang, Hanchen Liao, Xiaotian Huang, Qiong Liu   +14 more
wiley   +1 more source

High Levels of <i>Helicobacter pylori</i> Antimicrobial Resistance in Ireland-A Multicentre Study. [PDF]

Microorganisms
Butler TJ, Molloy S, Douglas A, Brennan D, FitzGerald R, Costigan C, Parihar V, Van Der Merwe K, Semenov S, Tighe D, Hough S, Kevans D, O'Morain C, McNamara D, Smith SM.   +14 more
europepmc   +1 more source

Prescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Tyrosine kinase inhibitors (TKIs) are essential in treating chronic myeloid leukaemia (CML) and other malignancies. Their absorption, however, is highly pH‐dependent, making them susceptible to interactions with acid‐suppressing agents such as proton pump inhibitors (PPIs), histamine‐2 receptor antagonists (H2RAs) and antacids ...
Marek Lapka, Anna Khryakova, Anastasiia Nazmutdinova, Chrysostomos Charalambous, Jan Bosak, Jiri Sliva   +5 more
wiley   +1 more source